C2i Genomics Launches C2inform MRD Test to Bring Distributed Cancer Monitoring to Cancer Centers Across Europe

C2i Genomics Applauded by Frost & Sullivan for Enabling Real-time Cancer Monitoring Using Genomic Data with Its C2intelligence Platform

The C2intelligence Platform enables custom, cost-effective, efficient, automatic, and globally accessible cancer data management and real-time monitoring. SAN ANTONIO...

C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection

Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for...

C2i Genomics Partners with OncoDNA to Bring AI-Powered Liquid Biopsy for Cancer Diagnostics Across Europe

C2i Genomics Named to the 2021 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups

C2i Genomics is Globalizing AI-Based Cancer Diagnostics and Monitoring | BioSpace

C2i Genomics Expands AI-Powered Cancer Detection and Monitoring Capabilities in US and China Through Partnership with NuProbe | WebWire

C2i Genomics Appoints Chief Medical Officer to Scale Its AI-Powered Cancer Detection Platform Globally | WebWire

C2i Genomics and Premier Inc. Team Up to Bring AI-Powered Personalized Cancer Detection and Treatment Monitoring to U.S. Healthcare Providers

C2i Genomics and NovogeneAIT Genomics Partner to Bring AI-Powered Cancer Detection to South East Asia